Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.
Eric J ChowSanjeev AggarwalDavid R DoodyRichard AplencSaro H ArmenianK Scott BakerSmita BhatiaNancy BlytheSteven D ColanLouis S ConstineDavid R FreyerLisa M KoppCaroline LaverdièreWendy M LeisenringNao SasakiLynda M VroomanBarbara L AsselinCindy L SchwartzSteven E LipshultzPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Among young adult-aged survivors of childhood cancer, dexrazoxane was associated with a cardioprotective effect nearly 20 years after initial anthracycline exposure.